Crossmark

Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis

Published Online: 2024-08-05

Published Print: 2024-11

Authors

Ren, Ruiqi

Zhang, Zhewei

Zhai, Shaokun

Yang, Jiahui

Tusong, BaihaiTihan

Wang, Jingzhou
License Information

Text and Data Mining valid from 2024-08-05

Version of Record valid from 2024-08-05
More Information

Article History

Received: 15 April 2024

Accepted: 20 July 2024

First Online: 5 August 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current